Page 134 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

110 F. David Carmona, Ana Márquez, Javier Martín et al.

[42] Gonzalez-Gay, M. A., Hajeer, A. H., Dababneh, A., et al. IL-6 promoter polymorphism
at position -174 modulates the phenotypic expression of polymyalgia rheumatica in
biopsy-proven giant cell arteritis. Clin. Exp. Rheumatol. 2002; 20:179-184.

[43] Makki, R. F., al Sharif, F., Gonzalez-Gay, M. A., et al. RANTES gene polymorphism in
polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin. Exp. Rheum.
2000; 18:391-393.

[44] Mattey, D. L., Hajeer, A. H., Dababneh, A., et al. Association of giant cell arteritis and
polymyalgia rheumatica with different tumor necrosis factor microsatellite
polymorphisms. Arthritis Rheum. 2000; 43:1749-1755.

[45] Palomino-Morales, R. J., Vazquez-Rodriguez, T. R., Torres, O., et al. Association
between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis. Arthritis Res.
Ther. 2010; 12:R51.

[46] Rodriguez-Rodriguez, L., Carmona, F. D., Castaneda, S., et al. Role of rs1343151
IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis. J.
Rheumatol. 2011; 38:889-892.

[47] Salvarani, C., Casali, B., Boiardi, L., et al. Intercellular adhesion molecule 1 gene
polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease
risk and severity. J. Rheumatol. 2000; 27:1215-1221.

[48] Boiardi, L., Casali, B., Nicoli, D., et al. Vascular endothelial growth factor gene
polymorphisms in giant cell arteritis. J. Rheumatol. 2003; 30:2160-2164.

[49] Rueda, B., Lopez-Nevot, M. A., Lopez-Diaz, M. J., et al. A functional variant of
vascular endothelial growth factor is associated with severe ischemic complications in
giant cell arteritis. J. Rheumatol. 2005; 32:1737-1741.

[50] Amoli, M. M., Garcia-Porrua, C., Llorca, J., et al. Endothelial nitric oxide synthase
haplotype associations in biopsy-proven giant cell arteritis. J. Rheumatol. 2003; 30:
2019-2022.

[51] Gonzalez-Gay, M. A., Oliver, J., Sanchez, E., et al. Association of a functional
inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven
giant cell arteritis. J. Rheumatol. 2005; 32:2178-2182.

[52] Salvarani, C., Casali, B., Nicoli, D., et al. Endothelial nitric oxide synthase gene
polymorphisms in giant cell arteritis. Arthritis Rheum. 2003; 48:3219-3223.

[53] Rodriguez-Pla, A., Beaty, T. H., Savino, P. J., et al. Association of a nonsynonymous
single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.
Arthritis Rheum. 2008; 58:1849-1853.

[54] Palomino-Morales, R., Torres, O., Vazquez-Rodriguez, T. R., et al. Association
between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.
J. Rheumatol. 2009; 36:1501-1506.

[55] Morgan, A. W., Robinson, J. I., Barrett, J. H., et al. Association of FCGR2A and
FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res.
Ther. 2006; 8:R109.

[56] Salvarani, C., Casali, B., Farnetti, E., et al. -463 G/A myeloperoxidase promoter
polymorphism in giant cell arteritis. Ann. Rheum. Dis. 2008; 67:485-488.

[57] Terao, C., Yoshifuji, H., Kimura, A., et al. Two Susceptibility Loci to Takayasu
Arteritis Reveal a Synergistic Role of the IL12B and HLA-B Regions in a Japanese
Population. Am. J. Hum. Genet. 2013 Jul. 2; [Epub. ahead of print].

Complimentary Contributor Copy